1 option
CADTH Canadian Drug Expert Committee recommendation : Insulin degludec (Tresiba - Novo Nordisk Canada Inc.) : indication : diabetes mellitus, types I and II / CADTH Canadian Drug Expert Committee.
- Format:
- Book
- Author/Creator:
- CADTH Canadian Drug Expert Committee, author, issuing body.
- Series:
- Common drug review clinical review report.
- Common drug review clinical review report
- Language:
- English
- Subjects (All):
- Oligonucleotides--Therapeutic use.
- Oligonucleotides.
- Physical Description:
- 1 online resource.
- Edition:
- First edition.
- Place of Publication:
- Ottawa, ON : Canadian Agency for Drugs and Technologies in Health, 2017.
- Summary:
- The CADTH Canadian Drug Expert Committee (CDEC) recommends that nusinersen be reimbursed for the treatment of 5q Spinal Muscular Atrophy (SMA).
- Notes:
- Description based on publisher supplied metadata and other sources.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.